Shareholders in Allianz are bracing for a packed fortnight that will test whether Europe’s largest insurer can sustain its recent momentum. The stock, trading just shy of its 52-week high at around €388, has climbed nearly 10% in recent weeks, pushing the group’s market capitalisation to roughly €148 billion. But with two pivotal events looming — the annual general meeting on 7 May and first-quarter earnings due on 13 May — the narrative is shifting from share-price euphoria to fundamental delivery.
A Dividend to Remember
The headline attraction for retail and institutional investors alike is the proposed payout. Management and the supervisory board are recommending a dividend of €17.10 per share for the 2025 financial year, an increase of roughly 11% from the prior year. At current levels, that translates into a yield of approximately 4.4%, with the cash distribution expected to land in accounts on 12 May. The payout continues a remarkable track record: over the past two decades, Allianz has raised its dividend 16 times and cut it only once, a statistic that the DZ Bank highlighted in a recent note when it reiterated its buy recommendation and fair-value estimate of €424.
India Deal Opens New Front
Just days before the AGM, Allianz cemented a strategic pivot into one of the world’s fastest-growing insurance markets. The company signed a binding agreement with Jio Financial Services, part of Mukesh Ambani’s sprawling Reliance conglomerate, to form a 50:50 joint venture targeting property and health insurance in India. The partnership will operate through Allianz Europe B.V. and grants the Munich-based group access to Jio’s vast digital distribution network — a critical advantage in a market where smartphone penetration is surging and traditional agency models are being disrupted.
This is not Allianz’s only recent expansion move. Its reinsurance arm, Allianz Re, has deepened ties with Openly, a US InsurTech start-up that specialises in technology-driven homeowners’ insurance. The venture arm Allianz X is also making a direct investment in the company, with the goal of embedding modern data models into risk assessment and scaling underwriting capacity.
Should investors sell immediately? Or is it worth buying Allianz?
Analyst Caution Amid the Optimism
Despite the flurry of positive headlines, not everyone is reaching for the calculator. RBC Capital Markets, in a note dated 23 April, maintained its “Sector Perform” rating and €400 price target, arguing that the recent rally has already priced in much of the good news. The bank’s updated estimates incorporate contributions from existing joint ventures but stop short of calling for further upside. The stock currently trades about 5% above its 200-day moving average, though it remains just below the recent peak of €394.80.
What the Q1 Numbers Will Reveal
The real test of Allianz’s trajectory will come on 13 May, when the group publishes its first-quarter results. Management has set an operating profit target of roughly €17.4 billion for the full year 2026, and the quarterly report will provide the first hard evidence of whether the company is on track. Market participants will be watching two segments in particular: property-casualty insurance and asset management, both of which are seen as bellwethers for the broader earnings picture. The India joint venture is unlikely to contribute materially at this stage, but analysts will be looking for any early signs of strategic traction.
For now, Allianz finds itself in an enviable position: a record dividend, a bold emerging-market bet, and a share price within striking distance of new highs. The next two weeks will determine whether the fundamentals can keep pace with the narrative.
Ad
Allianz Stock: Buy or Sell?! New Allianz Analysis from April 25 delivers the answer:
The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.
Allianz: Buy or sell? Read more here...
